Aim: Leukotrienes are important lipid inflammatory mediators that play a pivotal role in the pathogenesis of atherosclerosis. We aimed to construct a network of interactions between leukotrienes and inflammatory biomarkers and evaluate the expression of key members of the leukotriene pathway and leukotriene-induced inflammatory molecules in patients with coronary artery disease (CAD) and healthy controls. Methods: Leukotrienes and their regulatory inflammatory molecules reported in the literature were used to construct a biological network employing Gene spring GX v12.5. Key leukotriene genes and their closely interacting members were selected for expression study in 64 patients and 64 matched controls. Four single nucleotide polymorphisms (SNPs) (rs6538697, rs2660898, rs17525495 and rs1978331) in the leukotriene A4 hydrolase (LTA4H) gene were genotyped using SYBR green method, and plasma leukotriene B4 (LTB4) levels were measured using ELISA. 
Introduction
Extensive research supports the important role of inflammation in the manifestation and progression of coronary artery disease (CAD) 1) across different stages of atherosclerotic disease development, from initiation and progression to plaque rupture and thrombosis 2) . Leukotrienes are derived from arachidonic acid (AA) and function as potent mediators of inflammation 3) . Leukotriene synthesis is initiated by phospholipase A2 (PLA2), which catalyzes the hydrolysis of AA. The liberated free AA is further metabolized in the presence of arachidonate 5-lipoxygenase (ALOX5) in association with arachidonate 5-lipoxygenase-activating protein (ALOX5AP) to leukotriene A4 (LTA4). LTA4 is further hydrolyzed by leukotriene A4 hydrolase (LTA4H) to leukotriene B4 (LTB4) or metabolized to cysteinyl leukotrienes (LTC4, LTD4, LTE4) by the LTC4 synthase (LTC4S) enzyme 4) . LTB4 is a potent neutrophil chemotactic agent that facilitates the recruitment and adhesion of leukocytes to endothelial
Materials and Methods

Study Subjects
This study consisted of 64 CAD patients (cases) and 64 controls selected from participants of the Indian Atherosclerosis Research Study (IARS) 18) . Briefly, the IARS is an ongoing epidemiological study with the objective of investigating genetic factors and biomarkers against a backdrop of conventional cardiovascular risk factors in Asian Indians living in India. The recruitment of patients and controls was based on predefined inclusion/exclusion criteria. Patients were defined as subjects with abnormal electrocardiogram (ECG) findings, angiographically confirmed CAD having ＞70% stenosis in any one major epicardial artery or ＞50% stenosis in two or more arteries and those undergoing percutaneous transluminal coronary angioplasty or bypass graft surgery. The severity of CAD was defined based on the number of diseased coronary vessels as 1, 2 or 3 with ＞50% luminal narrowing.
The control subjects included healthy volunteers who were clinically asymptomatic for CAD and other inflammatory disorders, enrolled from the same geographical area as that of the proband, did not have a family history of cardiovascular disease and showed normal ECG readings. None of the participants had concomitant infections. All participants provided voluntary signed informed consent and the study was approved by the Institutional Ethics Committee and conducted in accordance with the guidelines of the Indian Council of Medical Research (ICMR) on bioethics 19) .
Clinical and Biochemical Assessment
Detailed demographics, anthropometrics, vital parameters, medical history, medication and pedigree information were recorded for each participant through personal interviews. Presence of hypertension and diabetes was ascertained based on self-report of a physician's diagnosis and/or use of prescription medications in addition to review of the medical records. Body mass index (BMI) was calculated as the body weight (kg) divided by the square of the height (m 2 ). Venous blood was collected after overnight fasting, and aliquots of serum and plasma were used for the biochemical analysis. Plasma levels of total cholesterol (TC), triglycerides (TG) and high-density lipoprotein-cholesterol (HDL-C) were measured using reagents obtained from Siemens Dimension Flex reagent cartridge (Siemens Healthcare Diagnostics Ltd, UK) and standards obtained from Randox laboratories (Crumlin, UK) on a Siemens dimension cells and possesses chemo-kinetic properties. In addition, LTB4 plays a pivotal role in immune modulation by inducing the production of cytokines, such as tumor necrosis factor (TNF) 5) and interleukin-6 (IL-6) 6) , under the influence of c-fos and c-jun transcription factors 7) . Furthermore, LTB4 stimulates nuclear factor kappa B (NF kappa B), which regulates the transcription of numerous inflammatory genes 8) . LTB4 also increases the production of interleukin-2 (IL-2), interferon gamma (IFN-gamma) and IL-5 by T cells and the expression of monocyte chemoattractant protein-1 (MCP-1) and IL-8 9) . Numerous studies have investigated the effects of the anti-inflammatory cytokines IL-4 and IL-10 on leukotriene synthesis, suggesting both positive and negative regulatory effects of these molecules. Previous studies have also demonstrated that IL-4 enhances the LTA4H activity, resulting in increased production of LTB4 10) . IL-4 inhibits LTB4 synthesis, providing further evidence of its antiinflammatory role 11) . An in vitro study reported that IL-10 does not regulate leukotriene production 10) , while an in vivo study involving the targeted disruption of the 5-LO gene (5LO −/− ) demonstrated increased IL-10 production, suggesting a negative regulatory effect on IL-10 production 12) . Therefore, complex relationships exist between leukotrienes and anti-inflammatory molecules. The analysis of human atherosclerotic plaque has demonstrated an abundant expression of 5-LO, ALOX5AP, LTA4H and LTC4S genes on the arterial walls in patients with cardiovascular disease [13] [14] [15] . Our previous study 16) and other epidemiological reports have shown that genetic variants in the LTA4H gene are associated with a higher LTB4 level 17) . Taken together, these data suggest that leukotrienes elicit an immune response by augmenting the inflammatory gene expression. However, the targeted expression of leukotrienes and inflammatory genes is not well understood. The goal of this study was therefore to elucidate the molecular expression patterns of inflammatory genes induced by leukotrienes in individuals with CAD. Such information may have the potential to provide predictive value for assessing cardiovascular risk. In particular, we focused on constructing a network of interactions between genes involved in leukotriene and inflammatory pathways in order to select those genes exhibiting maximum node connectivity and compare their expression levels between patients and controls. In addition, we measured plasma LTB4 levels and genotyped four functional SNPs in the LTA4H gene to study their associations with the LTA4H mRNA expression and plasma LTB4 levels. inflammatory molecules that are modulated by leukotrienes and vice versa. In this manner, we identified 31 genes, including leukotriene pathway genes, cytokines and chemokines, regulated by leukotrienes and transcription factors activated by LTB4. Each of these entities was shown to play a role in the atherosclerotic disease process.
Network Construction
The GeneSpring GX v 12.5 software program uses a proprietary Natural Language Processing (NLP) method wherein interactions are derived from PubMed articles and IntAct 25) based on the following relationships: binding, regulation, promoter binding, transport, metabolism, protein metabolism and expression, given a relation-score of ≥ 9. The network displays interactions among the entities and their neighboring genes, including those that are not included in the original entity list, thereby giving rise to nodes with different interrelationships. The complex network thus generated was further reanalyzed with a particular focus on leukotrienes and inflammatory Xpand plus instrument (Siemens Dade Behring, Liederbach, Germany). Liquicheck lipid control was used as an assayed quality control (Bio-Rad) in every experiment. Low-density lipoprotein-cholesterol (LDL-C) level was calculated using Friedewald's formula 20) .
Construction of Leukotriene-Inflammatory Interaction Network
A weighted network was constructed to understand the interactions of leukotriene pathway genes (ALOX5, ALOX5AP, LTA4H, LTC4S and PLA2G4A) and their product, LTB4, with leukotriene-induced inflammatory response genes and transcription factors that modulate them, using the GeneSpring GX v 12.5 software program. We selected 31 genes (entities) ( Table 1 ) based on data mining of the published literature [7] [8] [9] [21] [22] [23] [24] . The leukotriene interaction network was constructed using this list.
Gene Selection
The approach towards identifying lead entities began with literature survey. We first selected all 16) were genotyped using Tm shift method on a 7900 HT Fast Real-time PCR instrument (Applied Biosystems, Foster City, USA).
Statistical Analysis
All statistical procedures were performed using the SPSS v17.0 software program (SPSS Inc., Chicago, USA), and graphical representations were made using PRISM software program (version 4.0; GraphPad, San Diego, USA). Normality distribution of the mRNA expression and plasma LTB4 levels was assessed using Q-Q plot and outliers were removed prior to analysis. Variables that did not exhibit normal distribution (TC, TG, HDL-C) were logarithmically transformed before analysis. Student's t -test, ANOVA and univariate analysis were used to determine differences in the normalized mRNA expression levels and other quantitative traits between patients and controls, while chi-square test was used to estimate the association of categorical variables namely genotypes with CAD. Bonferroni correction was used to account for multiple testing. An age-and gender-adjusted Pearson correlation analysis was performed to evaluate the correlations between different biomarkers. Binary logistic regression analysis was used to estimate the association between mRNA expression and CAD and obtain the corresponding odds ratios (ORs). Analysis of the area under the receiver operating characteristic (ROC) curve was performed using R statistical program to assess the sensitivity of the prediction model in stratifying the patients and controls 29) . De Long method was helpful for estimating statistical significance between the different AUC models 30) . Goodness of fit for the logistic regression model was calculated using Hosmer-Lemeshow test. Net reclassification index (NRI) was used to assess improvements in predictive performance of the different risk prediction models 31) . Age, gender, hypertension, diabetes, TC and HDL-C were used as covariates and appropriately adjusted for during analysis. Continuous variables with a normal distribution are expressed as mean±standard error of the mean (SEM), and categorical variables are expressed as percentages. A nominal p value of ≤ 0.05 was considered to be statistically significant.
Results
Clinical Characteristics of Study Subjects
The characteristics of the study subjects are presented in Table 2 . Average age of participants was 50 years, with a higher proportion of men (89%) than women (11%). Hypertension and diabetes were more frequently observed among patients than in the conmarkers.
Finally, genes exhibiting high connectivity were selected for expression analysis using real-time PCR.
Sample Preparation and Real-Time PCR Assay
Total RNA was isolated from whole blood using RNeasy isolation kit (Qiagen Inc., Hilden, Germany) and reverse transcribed to cDNA using a cDNA archive kit (Applied Biosystems Inc., Foster City, USA), according to manufacturers' instructions. Quantitative RT-PCR was performed in duplicate on 7900 HT Fast Real-Time PCR system (Applied Biosystems, Foster City, USA) using TaqMan or SYBR green chemistry (Applied Biosystems, Foster City, USA).
The expression levels of ALOX5, ALOX5AP and LTA4H genes were measured using TaqMan chemistry. The primer/probe pairs were purchased from Applied Biosystems (Foster City, USA) with the following assay IDs: Hs01095330_m1 (ALOX5), Hs00233463_ m1 (ALOX5AP) and Hs1075882_ml (LTA4H). The primer pairs used for SYBR green based gene expression study were either selected from PrimerBank 26) or designed using PrimerQuest ® program (IDT, Coralville, USA). All primer sequences were further verified using BLAST search and are listed in Table  S1 . The real-time PCR efficiency of each primer pair was determined by constructing a standard curve with serial dilution of samples. Relative quantity was obtained with RQ Manager 1.2 software program (Applied Biosystems, Foster City, USA) according to comparative Ct method 27) following normalization to beta-glucuronidase (GUSB), an endogenous control, by determining the level of mRNA abundance in each sample relative to a reference sample (calibrator). Outliers were repeated in duplicate and persistent outliers were removed from further analyses.
LTB4 Immunoassay
LTB4 immunoassay was performed using EDTA plasma samples obtained from 64 patients and 64 matched controls using ELISA kit (Cayman Chemical Company, Ann Arbor, MI, USA) according to manufacturer's instructions. Sensitivity of the LTB4 assay was ＜20 pg/mL. The intra-and inter-assay coefficients of variation were ＜12%.
LTA4H SNP Genotyping
DNA was extracted from EDTA blood pellets following centrifugation and separation of plasma according to the modified salting out method 28) . Four variants in the LTA4H gene (rs6538697, rs2660898, rs17525495 and rs1978331) that were found to be significantly associated with LTB4 level in our earlier initial network with 31 genes pulled in 162 new entities such that it had 193 entities in total, as shown in Fig. S1 . Subsequently, leukotriene interaction partners were selected from the complex network to create a leukotriene-specific network that involved direct interactions with inflammatory genes. The biological and regulatory interactions between the leukotrienes and inflammatory molecules are shown in Fig. 1A and 1B. Strongly interconnected nodes were selected for expression analysis, which included five leukotriene pathway genes (ALOX5, ALOX5AP, LTA4H, LTC4S and PLA2G4A), eight inflammatory genes (TNF, IL-6, IL-8, IL-1beta, MCP-1, IFN-gamma, IL-10 and IL-4) and a key transcription factor and regulator of the inflammatory process (NF kappa B). The network exhibited high global connectivity for the pro-inflammatory genes TNF (23,230 nodes), IL-6 (12,865 nodes) and NF kappa B (10,730 nodes), as well as the trols. There were 35 (62.5%) patients with stable angina and 21 (37.5%) patients with a history of myocardial infarction (MI). Frequency distribution of subjects based on the number of diseased vessels was as follows: zero or one vessel −7 (12.3%), two vessels −18 (31.6%), three or more vessels −32 (56.1%). TC and LDL-C levels were lower in CAD patients than in controls, which may be attributed to the use of lipidlowering drugs in this group.
Candidate Gene Prioritization Using Network Analysis
The NLP network was constructed using an initial list of 31 genes (entities), as described in the methodology section. The network displays interactions among the entities and their neighboring genes that are not included in the original entity list, thereby giving rise to nodes with different interrelationships. The ) and TNF (1.795±0.124 vs 1.333±0.123; p = 0.01) between patients and controls after adjusting for potential confounders. Overall, patients showed higher levels of the entire repertoire of pro-inflammatory and leukotriene gene expression and lower levels of the anti-inflammatory gene expression than the controls. We noted significant differences in the expression levels of ALOX5, ALOX5AP, LTA4H, IL-1beta, IL-6, IL-8, IL-10, NF kappa B and TNF ( Fig. 2A) . IL-8 exhibited a four-fold higher expression in the patients than in the controls; this pattern remained even after adjusting for potential confounders. Plasma LTB4 levels were elevated in patients compared to the controls (84.135±5.617 pg/ mL vs 69.896±4.458 pg/mL; p = 0.071); however, the difference was not statistically significant (Fig. 2B) .
Analysis of Candidate Gene Expression with CAD Risk Factors and Disease Severity
A subset gene expression analysis of individuals with (n = 34) and without diabetes (n = 85) showed significant differences for ALOX5AP ( anti-inflammatory genes IL-4 (5901 nodes) and IL-10 (5281 nodes), implying that these molecules are biologically relevant for the development of inflammatory diseases such as CAD.
In the network, TNF displayed strong interconnectivity with ALOX5, ALOX5AP, PLA2G4A and LTB4. In fact, based on the relationships observed in this network, it appears that TNF exerts a priming effect on the regulation of 5-LO products. IL-8 demonstrated a positive regulatory effect on key enzymes involved in the biosynthesis of leukotrienes. Antiinflammatory genes IL-4 and IL-10 showed both positive and negative regulatory effects on the leukotriene pathway genes. A subnetwork interaction analysis of the relationships between LTB4 small molecules and inflammatory molecules revealed regulatory effects on the following genes: IL-6, IL-1beta, MCP-1 (also known as CCL2) and IFN-gamma.
Expression Analysis of Leukotrienes and Inflammatory Genes
Quantitative RT-PCR was used to validate select members of the leukotriene-inflammatory network in 64 patients and 64 controls. Outliers were removed using Q-Q plot. There were significant differences in the mean expression levels of ALOX5 (1.577±0.080 vs 1.182±0.074; p = 0.001), LTA4H (1.319±0.063 vs 1.070±0.058; p=0.01), IL-8 (7.120±0.606 vs 2.142± A B Fig. 2 . Real-time quantitative expression patterns of selected genes between the patients and controls.
Levels of candidate gene expression between the patients and controls. Gene expression levels in individual samples were normalized to GUSB mRNA level, Fig. 2 (A) . Levels of LTB4 in the patients and controls, Fig. 2 (B) . All data are presented as mean±SEM.
ations with CAD.
Performance of Discrimination Models
Five different models including the conventional risk factors and the mRNA expression levels of genes were tested for their ability to discriminate between the patient and control groups based on ROC analysis. The different prediction models included in the analysis were as follows: Model 1 = conventional risk factors (Fig. 4A) and 0.93 (0.89-0.97) with two genes (Fig. 4B) ; the corresponding incremental difference was statistically significant (Z =−3.52 and Z =−3.56) (p = 0.0004). In addition, NRI and IDI were found to be statistically significant upon addition of either five biomarkers (NRI = 0.43, 0.23-0.63; p＜0.001) or two biomarkers (NRI = 0.45, 0.26-0.64; p＜0.01), demonstrating an improvement in the predictive performance with the addition of these transcripts to the traditional risk factor model ( Table 3) . Both Model 2 and Model 3 showed good calibration according to (0.340±0.050 vs 0.220±0.019; p = 0.008) and TNF (1.960±0.180 vs 1.490±0.080; p = 0.01) genes demonstrated a higher expression in the subjects with diabetes before covariate adjustment only. In contrast, there were no significant differences in the gene expression levels between the subjects with and without hypertension. IFN-gamma gene expression showed an inverse association with the number of diseased vessels (1 vessel=0.733±0.140, 2 vessel=0.573±0.090, 3 and more vessels = 0.433±0.050), with the difference between three-vessel disease and one-vessel disease being statistically significant (p = 0.032).
Correlations between Leukotrienes and Inflammatory Genes
We observed positive correlation among genes in the leukotriene pathway: ALOX5, ALOX5AP, LTA4H and PLA2G4A (r = 0. 35 
Association between the LTA4H SNPs and Candidate Gene Expression
Four SNPs (rs6538697, rs2660898, rs17525495 and rs1978331) in the LTA4H gene showed significant association with LTA4H gene expression level, with the minor allele being associated with a lower LTA4H level (Fig. 3) . Following Bonferroni correction, only two SNPs, rs17525495 (p=0.027) and rs1978331 (p = 0.002), remained significant. In contrast, none of the variants showed significant association with plasma LTB4 level, although the minor allele of these two SNPs was associated with lower plasma LTB4 level.
Association of Leukotriene and Inflammatory Gene Expression with CAD
Logistic regression analysis revealed significant association of ALOX5, ALOX5AP, LTA4H, IL-1beta, IL-8 and TNF with CAD (Fig. S2) rs6538697 -T/C; rs2660898-T/G; rs17525495-C/T; rs1978331-T/C. In all SNPs, the minor alleles displayed considerably lower mRNA expression levels among the three genotypes.
in CAD patients and matched asymptomatic control subjects. Our key findings were as follows: a networkbased bioinformatics analysis showed TNF, IL-6, IL-8, IL-1beta, MCP-1, IFN-gamma, IL-10 and IL-4 genes to have high connectivity nodes with leukotriene pathway genes. Analysis of blood gene expression showed increased levels of ALOX5, LTA4H, IL-8 and TNF in patients compared to that observed in the controls. All of the nodal genes also exhibited an increased association with the risk of CAD, which enhances the potential clinical value of these markers. The combined expression values of these genes in different discrimination models showed a relatively powerful prognostic ability upon the addition of these markers to the traditional risk factor model. Finally, two LTA4H SNPs, rs17525495 and rs1978331, demonstrated significant association with LTA4H mRNA level.
The application of a systems biology approach has attracted attention for its ability to identify promising prognostic biomarkers, aiding in understanding underlying disease mechanisms 37, 38) . Systems biology is an interdisciplinary field of study that focuses on complex interactions within biological systems using a more holistic approach. In the present study, we used such an approach, allowing us to obtain a global view Hosmer Lemeshow test (p＞0.05).
Discussion
Inflammation plays a pivotal role in the manifestation of atherosclerosis, the underlying disease process in CAD, such that it may now be considered as an inflammatory disease 32) . The atherosclerotic disease process is initiated by the accumulation of lipid-containing lipoproteins, which evokes an inflammatory response in the arterial wall 33) . Inflammatory cells present in atherosclerotic lesions regulate the production of cytokines as well as other pro-and anti-inflammatory mediators during the disease process 34) . Understanding the central role of inflammation in atherosclerosis has encouraged the evaluation of inflammatory biomarkers for predicting atherosclerotic events 35) . Leukotrienes are potent lipid mediators that play a critical role in the pathogenesis of atherosclerosis by inducing pro-inflammatory signaling via the activation of specific receptors belonging to the superfamily of G protein-coupled receptors 36) . Hence, the main objectives of the present study were to evaluate the molecular interactions between leukotrienes and other inflammatory molecules using a systems biology approach and subsequently measure their expression The ROC curve for Model 2 includes five gene expression markers (ALOX5, ALOX5AP, LTA4H, IL-8 and TNF) combined with coronary artery disease (CAD) risk factors (CRF), Fig. 4 (A) . The ROC curve for Model 3 includes two gene expression markers (LTA4H and IL-8) combined with CRF, Fig. 4 (B) . Continuous line denotes the ROC curve for Model 1, which includes the CRFs, namely age, gender, hypertension, diabetes, total cholesterol and LDL-C. Dotted line represents the ROC analysis for CRF with the addition of gene expression markers.
A B gamma and IL-10 genes. These putative nodes (TNF, IL-8, IL-1beta, IL-4, IL-6, MCP-1, IFN-gamma and IL-10) and NF kappa B, which plays central role in the regulation of pro-inflammatory cytokines, were then selected to characterize the gene expression association patterns in individuals with CAD. We initially determined and compared the expression patterns of the genes in the leukotriene pathway and observed a significantly higher expression of ALOX5 and LTA4H in the patients than in the healthy controls. It has been reported that ALOX5, ALOX5AP and LTA4H, which co-localize in macrophages, are abundantly expressed in atherosclerotic lesions and correlate with the disease state 14) . We did not observe any significant changes in the expression of LTC4S mRNA, which corroborates with the findings of other published reports focusing on human atherosclerotic lesions 14) . There were significant correlations between the levels of ALOX5, ALOX5AP and LTA4H, but not LTB4, the final metabolite in this pathway. Differences in the gene expression at the transcriptome and protein levels may be ascribed to posttranslational modification 39) or other regulatory mechanisms. Current research on the underlying disease mechanisms involved in atherosclerosis has provided substantial evidence regarding the role of cytokines in the development, progression and complications of atherosclerosis 40) . It has been shown that leukotrienes can modulate the cytokine-mediated effects of inflammation driving the immune response 21) . TNF is a wellknown pro-inflammatory cytokine that promotes atherosclerosis, and studies have demonstrated that it can exert a very potent priming effect on the biosynthesis of 5-LO production 41) . A study by Tobin et al. suggested that LTA4H can influence the TNF level, resulting in macrophage necrosis, thereby contributing of inflammatory interactions with leukotrienes, which has not been adequately elucidated to date. The interaction network constructed using the Gene Spring GX v12.5 program with an initial set of 31 genes resulted in a complex interaction network that was customized to select only leukotriene gene integrators, as shown in Fig. 1 . This network illustrates the relationships between entities identified from literature using a natural language processing algorithm. The relationships represent different kinds of molecular interactions among the entities, which play the role of either regulator, target, reactant or product. All relationships derived had a relation-score of 9, indicating that only strong interactions were selected in this study. Fig. 1 (A) shows ALOX5 and PLA2G4A as key regulators of many molecules and LTB4 as the central metabolite linking them. Relationships based on regulation show that ALOX5 regulates TNF and inflammatory molecules, such as IL-8, and that IL-1beta regulates ALOX5, while PLA2G4A positively regulates IL-8, TNF and IL-1beta. Furthermore, based on the pattern of expression, IL-10 upregulates ALOX5, TNF regulates ALOX5 and ALOX5AP, IL-6 upregulates PLA2G4A and IL-4 upregulates LTC4S and negatively regulates PLA2G4A. Fig. 1 (B) depicts the interactions between the small molecule LTB4, the final metabolite of the leukotriene pathway, and PLA2G4A, ALOX5, ALOX5AP, LTA4H, IL-6, IL-4, IL-1beta, IL-8, TNF and MCP-1, indicating two-way relationships. Graphical representation of the interaction network indicates TNF to be a highly connected node associated with all genes in the leukotriene pathway, followed by other nodes, including IL-8, IL-4 and IL-1beta. Several nodes, namely IL-8, IL-1beta, TNF, IL-4, MCP-1 and IL-6, showed high connectivity with the plasma LTB4 level, followed by the IFN- whereas, in an in vivo study of a 5LO −/− knockout mouse model, a higher IL-10 production was found to be associated with a concomitant decrease in the levels of inflammatory cytokines 12) . These differences may be attributed to the specific types of cells, type of stimulus and strain of mouse used in the different studies. Furthermore, the leukotriene pathway exhibits differences between murine and human atherosclerosis, wherein mouse models lack this pathway in advanced lesions 49) . This issue warrants a detailed investigation to understand the role of inflammatory cytokines in human samples.
Our pilot genetic association study showed that the plasma LTB4 level may modulate the risk of CAD 16) . Other functional studies have demonstrated increased LTB4 production in stimulated monocytes obtained from subjects carrying Haplotype K (HapK) of the LTA4H gene 50) . LTB4 is a direct product of the reaction catalyzed by LTA4H enzyme, providing a biologically plausible mechanism for the increased risk of CAD induced by LTA4H variants. We observed a promoter SNP (rs17525495) and an intronic SNP (rs1978331) in the LTA4H gene to be significantly associated with LTA4H mRNA level, wherein the homozygous rare alleles of both the SNPs shows a protective effect. In fact, the intronic SNP is in strong linkage disequilibrium with the promoter SNP, which may provide a likely explanation for the observed association with the LTA4H mRNA expression. Although we did not observe any significant associations between these variants and plasma LTB4 level, the minor alleles of these two SNPs were found to be associated with lower plasma LTB4 level. This finding may probably be attributed to the modulation of LTA4H locus in a manner that brings about a balance between pro-and anti-inflammatory eicosanoids 42) .
Limitations
We acknowledge certain limitations in this study. The interaction network was obtained based on a priori knowledge that high trafficking nodes may be those with a greater number of published reports, which does not give sufficient weightage to those interactions on which few studies have been conducted. In addition, the sample size in the present study was small, with a higher proportion of men, including only 11% women, which may therefore lend a gender bias to the findings. As this exploratory study revealed some interesting and novel findings, this issue warrants extended investigation in a larger cohort with equal representation of men and women.
to the pathogenesis of immune disease 42) . Furthermore, elevated TNF level has been shown to increase the risk of recurrent coronary events 43) . In the present study, the TNF levels were high in patients and correlated with ALOX5, ALOX5AP and LTA4H expression levels.
IL-8 is a potent angiogenic factor that plays an important role in atherosclerosis 44) . It has been demonstrated that LTB4, which is produced by neutrophils, promotes the IL-8 expression in monocytes, thereby contributing to an augmented inflammatory response 45) . Reports have also suggested significant correlations of LTB4 with TNF and IL-8 levels 46) . The present results demonstrated four-fold higher expression levels of IL-8 in patients, and positive correlations with ALOX5, ALOX5AP, LTA4H and TNF, thus supporting the notion that leukotrienes mediate the release of inflammatory cytokines. Patients exhibited higher levels of IL-6, IL-1beta and NF kappa B than the controls, although the differences did not reach statistical significance. In contrast, we observed the levels of IFN-gamma to be lower in the patients than in the controls. In fact, IFN-gamma, in addition to acting as a local pro-inflammatory cytokine, has been shown to exert counter-inflammatory effects under specific conditions 47) . IFN-gamma levels were lower in patients with three-vessel disease than in those with one-vessel disease, indicating that the cardioprotective effect increases in association with disease severity. Furthermore, we evaluated the diagnostic value of mRNA levels of the candidate genes using a ROC analysis, the results of which showed that LTA4H and IL-8 provide higher accuracy for distinguishing CAD patients from controls than the use of conventional risk factors alone.
We also examined the associations between the anti-inflammatory cytokines IL-4 and IL-10 in the CAD patients and their correlations with the leukotriene gene expression. Our findings demonstrated a lower expression of IL-10 in the patients prior to covariate adjustment, with a strong correlation to ALOX5AP. The effects of anti-inflammatory cytokines on the regulation of arachidonic acid metabolites are less clear. An in vitro study by Zaitsu et al. reported that IL-4 and IL-13 increase the mRNA expression and protein synthesis of LTA4H, thus leading to a higher level of LTB4 production, while IL-10 does not show a similar effect 10) . In contrast, in an ex vivo study, IL-10 was found to exert a stimulatory effect on the synthesis of pro-inflammatory cytokines 5) . Furthermore, it has been demonstrated that IL-10 reduces the leukotriene production by inhibiting the induction of arachidonate 5-lipoxygenase-activating proteins 48) , 
